(Q39395549)

11 September 2017

Roles of HIF-1α in a novel optical orthotopic spontaneous metastatic bladder cancer animal model (English)

1 reference

11 September 2017

1 reference

Tingting Zhang

1

1 reference

11 September 2017

Jinhai Fan

2

1 reference

11 September 2017

Kaijie Wu

3

1 reference

11 September 2017

Jin Zeng

4

1 reference

11 September 2017

Kangwei Sun

5

1 reference

11 September 2017

Zhenfeng Guan

6

1 reference

11 September 2017

Xinyang Wang

7

1 reference

11 September 2017

Jer-Tsong Hiesh

8

1 reference

11 September 2017

Dalin He

9

1 reference

11 September 2017

14 February 2012

1 reference

11 September 2017

1 reference

11 September 2017

30

1 reference

11 September 2017

928-935

1 reference

11 September 2017

6

1 reference

Glycogen synthase kinase-3beta: a prognostic marker and a potential therapeutic target in human bladder cancer

11 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.01.003

Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.01.003

Invasion and metastasis models for studying RhoGDI2 in bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.01.003

Profiling the evolution of human metastatic bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.01.003

Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.01.003

Hypoxia, inflammation, and the tumor microenvironment in metastatic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.01.003

Expression of hypoxia-associated proteins in sporadic medullary thyroid cancer is associated with desmoplastic stroma reaction and lymph node metastasis and may indicate somatic mutations in the VHL gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.01.003

Low ascorbate levels are associated with increased hypoxia-inducible factor-1 activity and an aggressive tumor phenotype in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.01.003

Tumour-educated macrophages promote tumour progression and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.01.003

Hypoxia-inducible factor 1alpha regulates lung adenocarcinoma cell invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.01.003

Upregulation of TRAG3 gene in urothelial carcinoma of the bladder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.01.003

Human eotaxin represents a potent activator of the respiratory burst of human eosinophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.01.003

Human neural cell adhesion molecule L1 and rat homologue NILE are ligands for integrin alpha v beta 3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.01.003

Is eligibility for a chemotherapy protocol a good prognostic factor for invasive bladder cancer after radical cystectomy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.01.003

New functions for the matrix metalloproteinases in cancer progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.01.003

Strategies for MMP inhibition in cancer: innovations for the post-trial era.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.01.003

Hypoxia-Inducible Factor-1 Expression Predicts a Poor Response to Primary Chemoendocrine Therapy and Disease-Free Survival in Primary Human Breast Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.01.003

Over expression of hypoxia-inducible factor-1alpha in renal and bladder cancer cells increases tumorigenic potency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.01.003

Hypoxia-inducible factor-1α and -2α are expressed in most rectal cancers but only hypoxia-inducible factor-1α is associated with prognosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.01.003

Hypoxia-inducible factor 1alpha expression as an intrinsic marker of hypoxia: correlation with tumor oxygen, pimonidazole measurements, and outcome in locally advanced carcinoma of the cervix.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.01.003

Expression of hypoxia-inducible factor (HIF)-1alpha is associated with vascular endothelial growth factor expression and tumour angiogenesis in human oesophageal squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2012.01.003

10.1016/J.UROLONC.2012.01.003

7 January 2021

Identifiers

DOI

1 reference

11 September 2017

1 reference